before or after 24 hours). In algorithms using two limb measurements there are also differences -inclusion of saturations <95% in one or both limbs and the absolute value of the differential between the two in determining positive results. 1 So, which algorithm is best?
When evaluating algorithms, it is important to consider sensitivity, specificity, false positive (FP) and false negative rate. It is also vital that screening leads to timely diagnosis -before presentation with acute collapse. Meta-analysis of POS studies shows that overall, the test has modest sensitivity (~ 75%) and high specificity (99.8%), with no significant difference in sensitivity between pre/post vs. post-ductal testing or timing. 3 However, analysis of raw saturation data from babies who had both limb measurements, shows that some babies with CCHD would be missed by post-ductal testing alone. 1 In addition, the FP rate is significantly higher with earlier testing (<24 hrs). 3 These factors were deemed important by the USA workgroup considering the POS evidence and their recommendation was that screening should 
Timing of the test
In published studies that adopted earlier screening, 3, 6 the FP rate was higher, but more non-cardiac disease was identified; this is because such babies are more likely to develop hypoxemia within 24 hours and therefore be picked up by earlier screening. the earlier these are identified, the better. In some countries, mothers and babies are discharged from hospital within 24 hours following birth and an increasing proportion is born at home. In these circumstances, later screening in hospital is not practical.
UK evidence -screening at a mean age of seven hours -reported a test positive rate of 0.8% 7 (similar to PulseOx study 6 ) With around 26 000 babies screened, nine CCHDs were identified and, within the FPs, 79% had a significant medical condition. One of the major concerns regarding a high FP rate is the increased need for specialist assessment -particularly echocardiography -which can be challenging in some areas. Only 29% of test-positive babies in the UK study underwent echocardiography (mainly because an alternative non-cardiac diagnosis was established) and the echo was positive in 48%. 7 This compared favorably with babies in the same unit undergoing echocardiography for asymptomatic murmur 7 The experience following the introduction of POS in New Jersey was recently reported. 8 Almost 73 000 babies were screened (after 24 hours) and the FP rate was 0.04%. However only three babies with CCHD and only 12 babies with noncardiac conditions were detected. Although the FP rate is admirably low, the number of babies with CCHD is also very low. In the UK it took 2873 screens to detect one CCHD vs. 24 231 screens in the US. 7 The likelihood is, that in the US cohort, many babies with CCHD presented before screening took place. These important considerations led to the Nordic countries recommending screening at <24 hours 9
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The evidence to support a change in timing is perhaps more convincing, but is important to accept that test positives will increase (to around 0.8%) with earlier screening and many non-cardiac conditions are identified in addition.
POS uses hypoxemia as a proxy for CCHD and does not detect CCHD directly.
Given this, should we screen for all hypoxemic conditions rather than just CCHD?
The concern is that hypoxemia is not a condition as such and newborns may have 'physiological' hypoxemia as the cardio-respiratory systems adapt to extrauterine life. Once again the earlier screening takes place the more likely this 'transitional circulation' is identified in test positive babies. The other major concern is although we have good data for CCHD, there are no robust data on the accuracy of POS for non-cardiac conditions. This presents difficulties for Public
Health decision-makers sanctioning POS as a valid test for these conditions.
Perhaps the best compromise is to continue POS for CCHD and accept that babies detected with non-cardiac conditions (technically FPs, but could be considered secondary targets) are an important additional benefit. Clinical staff and parents should be made aware of this.
Until these issues are resolved and more data forthcoming, is it worth considering an algorithm which has a consistent slightly higher FP rate but will potentially identify more babies with life-threatening disease?
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